Modelling in preclinical and clinical drug development

被引：1

作者：

Balant, LP ^{[1
]}

Gex-Fabry, M ^{[1
]}

机构：

[1] Univ Geneva, Dept Psychiat, CH-1225 Chene Bourg, Switzerland

来源：

PHARMACOKINETIC OPTIMIZATION IN DRUG RESEARCH: BIOLOGICAL, PHYSICOCHEMICAL, AND COMPUTATIONAL STRATEGIES | 2001年

关键词：

D O I：

10.1002/9783906390437.ch2

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：15 / 29

页数：15

共 73 条

[41] A fractal approach to heterogeneous drug distribution: Calcium pharmacokinetics [J].

Macheras, P .

PHARMACEUTICAL RESEARCH, 1996, 13 (05) :663-670

[42] Interspecies scaling: Predicting volumes, mean residence time and elimination half-life. Some suggestions [J].

Mahmood, I .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (05) :493-499

[43] Interspecies scaling: A comparative study for the prediction of clearance and volume using two or more than two species [J].

Mahmood, I ;

Balian, JD .

LIFE SCIENCES, 1996, 59 (07) :579-585

[44] Interspecies scaling of renally secreted drugs [J].

Mahmood, I .

LIFE SCIENCES, 1998, 63 (26) :2365-2371

[45] The pharmacokinetic principles behind scaling from preclinical results to phase I protocols [J].

Mahmood, I ;

Balian, JD .

CLINICAL PHARMACOKINETICS, 1999, 36 (01) :1-11

[46] Expanding clinical applications of population pharmacodynamic modelling [J].

Minto, C ;

Schnider, T .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (04) :321-333

[47]

Obach RS, 1997, J PHARMACOL EXP THER, V283, P46

[48] PHARMACOKINETIC STUDIES IN HEALTHY-VOLUNTEERS IN THE CONTEXT OF INVITRO INVIVO CORRELATIONS [J].

OOSTERHUIS, B ;

JONKMAN, JHG .

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1993, 18 (01) :19-30

[49] Link between drug absorption solubility and permeability measurements in Caco-2 cells [J].

Pade, V ;

Stavchansky, S .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (12) :1604-1607

[50] An evaluation of the integration of pharmacokinetic and pharmacodynamic principles in clinical drug development - Experience within Hoffmann La Roche [J].

Reigner, BG ;

Williams, PEO ;

Patel, JH ;

Steimer, JL ;

Peck, C ;

vanBrummelen, P .

CLINICAL PHARMACOKINETICS, 1997, 33 (02) :142-152

← 1 2 3 4 5 6 7 8 →